Orange Book product · Generic (ANDA)
HALOPERIDOL DECANOATE
HALOPERIDOL DECANOATE
At a glance
Dec 19, 1997
Approved
Generic (ANDA)
Application
AO
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 19, 1997
28 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
HALOPERIDOL DECANOATE
Strength
EQ 50MG BASE/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AO
Application
ANDA 074893
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of HALOPERIDOL DECANOATE
- 1986HALDOLBrand (NDA)
NDA 018701 · JANSSEN PHARMS
- 2025HALOPERIDOL DECANOATEGeneric (ANDA)
ANDA 219168 · CAPLIN
- 2023HALOPERIDOL DECANOATEGeneric (ANDA)
ANDA 216730 · MANKIND PHARMA
- 2021HALOPERIDOL DECANOATEGeneric (ANDA)
ANDA 214507 · MEITHEAL
- 2019HALOPERIDOL DECANOATEGeneric (ANDA)
ANDA 211180 · ZYDUS PHARMS
- 2018HALOPERIDOL DECANOATEGeneric (ANDA)
ANDA 209101 · SOMERSET THERAPS LLC
- 2017HALOPERIDOL DECANOATEGeneric (ANDA)
ANDA 205241 · GLAND
- 2005HALOPERIDOL DECANOATEGeneric (ANDA)
ANDA 076463 · SANDOZ
- 2000HALOPERIDOL DECANOATEGeneric (ANDA)
ANDA 075440 · MYLAN LABS LTD
- 2000HALOPERIDOL DECANOATEGeneric (ANDA)
ANDA 075176 · HOSPIRA
- 1999HALOPERIDOL DECANOATEGeneric (ANDA)
ANDA 075393 · TEVA PHARMS USA
- 1998HALOPERIDOL DECANOATEGeneric (ANDA)
ANDA 075305 · HIKMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
